OTCPK:IMEX.F

Stock Analysis Report

Executive Summary

Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.

Risks

  • Imagin Medical has significant price volatility in the past 3 months.
  • Imagin Medical is not covered by any analysts.

Share Price & News

How has Imagin Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-3.1%

IMEX.F

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

-65.8%

IMEX.F

9.5%

US Medical Equipment

1.1%

US Market

IMEX.F underperformed the Medical Equipment industry which returned 9.7% over the past year.

IMEX.F underperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

IMEX.FIndustryMarket
7 Day-3.1%0.7%-0.2%
30 Day-6.7%0.1%2.5%
90 Day-6.7%2.5%1.6%
1 Year-65.8%-65.8%10.4%9.5%3.4%1.1%
3 Year-39.2%-39.2%69.3%64.1%45.2%35.8%
5 Yearn/a138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is Imagin Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Imagin Medical undervalued based on future cash flows and its price relative to the stock market?

2.43x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Imagin Medical to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Imagin Medical to establish if it is available at substantial discount.


Price Based on Earnings

Imagin Medical is loss making, we can't compare its value to the US Medical Equipment industry average.

Imagin Medical is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Imagin Medical, we can't assess if its growth is good value.


Price Based on Value of Assets

Imagin Medical is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Imagin Medical expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Imagin Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Imagin Medical performed over the past 5 years?

-50.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Imagin Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Imagin Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Imagin Medical's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Imagin Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Imagin Medical has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Imagin Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Imagin Medical's financial position?


Financial Position Analysis

Imagin Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Imagin Medical has no long term commitments.


Debt to Equity History and Analysis

Imagin Medical has no debt.

Imagin Medical currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet

Low level of unsold assets.

Imagin Medical has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Imagin Medical has less than a year of cash runway based on current free cash flow.

Imagin Medical has less than a year of cash runway if free cash flow continues to grow at historical rates of 47.4% each year.


Next Steps

Dividend

What is Imagin Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Imagin Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Imagin Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Imagin Medical has not reported any payouts.

Unable to verify if Imagin Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Imagin Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Imagin Medical's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average board tenure


CEO

Jim Hutchens 0

3.6yrs

Tenure

CA$1,643,857

Compensation

Mr. Edward James Hutchens, also known as Jim, is the Co-founder and Managing Director of Origin Partners. Mr. Hutchens has been Chief Executive Officer and President of Imagin Medical Inc. since February 2 ...


CEO Compensation Analysis

Jim's remuneration is higher than average for companies of similar size in United States of America.

Jim's compensation has increased whilst company is loss making.


Board Age and Tenure

2.9yrs

Average Tenure

The average tenure for the Imagin Medical board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyCA$5,00018 Jun 19
Christopher Bleck
EntityIndividual
Role
Member of the Board of Directors
Director
Shares83,472
Max PriceCA$0.06
BuyCA$6,21112 Jun 19
Edward Hutchens
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares100,000
Max PriceCA$0.064
BuyCA$5,56712 Jun 19
Kenneth Daignault
EntityIndividual
Role
Member of the Board of Directors
Director
Shares82,236
Max PriceCA$0.068
BuyCA$4,77012 Jun 19
John Vacha
EntityIndividual
Role
Member of the Board of Directors
CFO, Corporate Secretary & Director
Shares72,000
Max PriceCA$0.068

Ownership Breakdown


Management Team

  • Jim Hutchens

    CEO, President & Director

    • Tenure: 3.6yrs
    • Compensation: CA$1.64m
  • John Vacha

    CFO, Corporate Secretary & Director

    • Tenure: 1.7yrs
    • Compensation: CA$260.11k
  • Thom McMahon

    Director of Sales

    • Tenure: 0yrs

Board Members

  • Chris Bleck (62yo)

    Director

    • Tenure: 0.9yrs
  • Jim Hutchens

    CEO, President & Director

    • Tenure: 3.6yrs
    • Compensation: CA$1.64m
  • John Vacha

    CFO, Corporate Secretary & Director

    • Tenure: 1.7yrs
    • Compensation: CA$260.11k
  • Ralph de Vere White

    Chairman of Scientific Medical Advisory Board

    • Tenure: 3.4yrs
  • Edward Messing

    Member of Scientific Medical Advisory Board

    • Tenure: 3yrs
  • Ashish Kamat

    Member of Scientific Advisory Board

    • Tenure: 0.4yrs
  • Robin Atlas (67yo)

    Chairperson

    • Tenure: 0yrs
    • Compensation: CA$6.00k
  • Ken Daignault

    Director

    • Tenure: 3yrs
    • Compensation: CA$38.01k
  • Liam Hurley

    Member of Scientific Medical Advisory Board

    • Tenure: 2.9yrs
  • Roger Buckley

    Member of Scientific Medical Advisory Board

    • Tenure: 2.8yrs

Company Information

Imagin Medical Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Imagin Medical Inc.
  • Ticker: IMEX.F
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$8.344m
  • Listing Market Cap: CA$6.287m
  • Shares outstanding: 139.06m
  • Website: https://imaginmedical.com

Location

  • Imagin Medical Inc.
  • 890 West Pender Street
  • Suite 600
  • Vancouver
  • British Columbia
  • V6C 1L9
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DPD2DB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2016
IMEX.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2016
IMECNSX (Canadian National Stock Exchange)YesCommon SharesCACADFeb 2016

Biography

Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes. Its ultrasensitive imaging technology is based on improved optical designs and a ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 00:24
End of Day Share Price2019/09/17 00:00
Earnings2019/06/30
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.